Explore how IMMU-110, an antibody-drug conjugate, targets CD74 in multiple myeloma with precision cancer therapy approach.
Explore how antibody-based drugs and recombinant proteins are transforming the diagnosis and treatment of viral infections, autoimmune diseases, and cancer through targeted therapies.
New research reveals how glioblastoma cells escape IL-13Rα2-targeted therapy and why these escapees become less aggressive, offering new therapeutic opportunities.